bioRxivBiochemistry
Missing the sweet spot: one of the two N-glycans on human Gb3/CD77 synthase is expendable
K. Mikolajczyk, A. Bereznicka, K. Szymczak-Kulus, K. Haczkiewicz-Lesniak, B. Szulc, M. Olczak, J. Rossowska, E. Majorczyk, K. Kapczynska, N. V. Bovin, M. Lisowska, R. Kaczmarek, A. Miazek, M. Czerwinski
Abstract
N-glycosylation is a ubiquitous posttranslational modification that may influence folding, subcellular localization, secretion, solubility and oligomerization of proteins. In this study, we examined the effects of N-glycans on the activity of human Gb3/CD77 synthase, which catalyzes the synthesis of glycosphingolipids with terminal Gal1[->]4Gal (Gb3 and the P1 antigen) and Gal1[->]4GalNAc disaccharides (the NOR antigen). The human Gb3/CD77 synthase contains two occupied N-glycosylation sites at positions N121 and N203. Intriguingly, we found that while the N-glycan at N203 is essential for activity and correct subcellular localization, the N-glycan at N121 is dispensable and its absence did not reduce, but, surprisingly, even increased the activity of the enzyme. The fully N-glycosylated human Gb3/CD77 synthase and its glycoform missing the N121 glycan correctly localized in the Golgi, whereas a glycoform without the N203 site partially mislocalized in the endoplasmic reticulum. A double mutein missing both N-glycans was inactive and accumulated in the endoplasmic reticulum. Our results suggest that the decreased specific activity of human Gb3/CD77 synthase glycovariants results from their improper subcellular localization and, to a smaller degree, a decrease in enzyme solubility. Taken together, our findings show that the two N-glycans of human Gb3/CD77 synthase have opposing effects on its properties, revealing a dual nature of N-glycosylation and potentially a novel regulatory mechanism controlling the biological activity of proteins.
- organism: human
- assay: protein structure
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Expression of a human Gb3/CD77 synthase in insect and human cells: comparison of activity and glycosylation
Krzysztof P. Mikolajczyk, Katarzyna Szymczak-Kulus, … Marcin Czerwiński·Protein Expression and PurificationPeer-reviewed·Aug 18, 2025
- A Cytosolic Reductase Pathway is Required for Complete N-Glycosylation of an STT3B-Dependent Acceptor Site.
M. van Lith, M. A. Pringle, … N. J. Bulleid·bioRxiv·Aug 31, 2021
- Sequential in vitro enzymatic N-glycoprotein modification reveals site-specific rates of glycoenzyme processing
T. M. Adams, P. Zhao, … L. Wells·bioRxiv·Jul 27, 2022
- Identification and characterization of a novel exo-(N-)glycanase activity of NGLY1 on ENGase-digested N-GlcNAc proteins in vitro
Yilin Ye, Xinrong Lu, … Guiqin Sun·bioRxiv·Aug 21, 2025
- Structure of human endo-α-1,2-mannosidase (MANEA), an antiviral host-glycosylation target
L. F. Sobala, P. Z. Fernandes, … G. J. Davies·bioRxiv·Jun 30, 2020
- N-glycosylation blocks and simultaneously fosters different receptor-ligand binding sites: the chameleonic CD44-hyaluronan interaction
Joni Vuorio, Jana Škerlová, … Hector Martinez‐Seara·bioRxiv·Mar 23, 2020